Kayexalate Trademark Details

Kayexalate was registered on Tuesday, September 23, 1958 and is currently owned by Sanofi-Aventis U.S. LLC under the registration number 667320 . This mark is alive with a status of Registered and Renewed. The last case file activity for this mark occured 14 years ago on Thursday, September 25, 2008, according to the United State Patent & Trademark Office
Word Mark Kayexalate
Status Alive Registered 800 — Registered and Renewed

Current Owner

Sanofi-Aventis U.S. LLC of Bridgewater, NJ

View all trademarks for Sanofi-Aventis U.S. LLC
Other Trademarks for Sanofi-Aventis U.S. LLC

Previous Owners

Sanofi Pharmaceuticals, Inc. of New York, NY

View all trademarks for Sanofi Pharmaceuticals, Inc.
Other Trademarks for Sanofi Pharmaceuticals, Inc.

Sterling Drug Inc. of NEW YORK 18, NY

View all trademarks for Sterling Drug Inc.
Other Trademarks for Sterling Drug Inc.

Concordia Pharmaceuticals Inc.

View all trademarks for Concordia Pharmaceuticals Inc.
Serial Number 72044216
Registration Number 667320
Status Date Thursday, September 25, 2008
Filing Date Thursday, September 25, 2008
Registration Date Tuesday, September 23, 1958
Attorney Rita M. Carrier

Correspondent

Rita M. Carrier
Sullivan & Cromwell LLP
1700 New York Avenue, N.W.
Suite 700
Washington, DC 20006-5215

Case File Statements

Amendment to a Registration/Renewal Certificate Issue New Certificate to: CONCORDIA PHARMACEUTICALS INC. (LUXEMBOURG PRIVATE LIMITED LIABILITY COMPANY) 8-10, Avenue de la Gare Luxembourg L-1610 Luxembourg.
Goods & Services Cationic Exchange Resin for the Treatment of Hyperkalemia

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 018
Status 6 — Active
Status Date Tuesday, March 1, 1983
First Use Anywhere Friday, December 20, 1957
First Use In Commerce Friday, December 20, 1957
Primary Code 018

You must be signed in to print.

Once signed in, look for the PDF button.